Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Individualized Education for Bortezomib-Related Symptom Management in Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
A Open-Label Phase in Participants With Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate the Subcutaneous Belantamab (BCMAb) Formulation Versus Intravenous Belantamab in Participants With Multiple Myeloma While Treated With Standard of Care
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Iberdomide (CC-220) Priming to Improve T Cell Fitness Prior to Leukapheresis for Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Relapsed/Refractory Multiple Myeloma (RRMM)
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Monitoring MRD in Multiple Myeloma in Serum by Mass Spectrometry
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
GMMG-HD11/DSMM XXI/64007957MMY3010
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Delayed Toxicities Post-CAR-T
- Status
- RECRUITING
- Phase
- N/A
Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- N/A
A Clinical Study of SHR-5421 in Patients With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
CM336-SOC for Dynamically High-Risk Multiple Myeloma Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Digital Support for Multiple Myeloma Quality of Life
- Status
- RECRUITING
- Phase
- NA
A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3